Neoadjuvant Therapy for Locally Advanced Colon Cancer
NCT04625803
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Neoadjuvant Therapy
Interventions
DRUG:
Camrelizumab , apatinib and chemotherapy
Sponsor
Zhejiang University